JPH0218068B2 - - Google Patents
Info
- Publication number
- JPH0218068B2 JPH0218068B2 JP19013584A JP19013584A JPH0218068B2 JP H0218068 B2 JPH0218068 B2 JP H0218068B2 JP 19013584 A JP19013584 A JP 19013584A JP 19013584 A JP19013584 A JP 19013584A JP H0218068 B2 JPH0218068 B2 JP H0218068B2
- Authority
- JP
- Japan
- Prior art keywords
- creatine
- culture
- enzyme
- creatine amidinohydrolase
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108010077078 Creatinase Proteins 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 13
- 241000589291 Acinetobacter Species 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000012258 culturing Methods 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 26
- 108090000790 Enzymes Proteins 0.000 description 20
- 102000004190 Enzymes Human genes 0.000 description 20
- 239000000243 solution Substances 0.000 description 17
- 239000006046 creatine Substances 0.000 description 13
- 229960003624 creatine Drugs 0.000 description 13
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 8
- 229940109239 creatinine Drugs 0.000 description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 108010077895 Sarcosine Proteins 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000006114 decarboxylation reaction Methods 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 229940043230 sarcosine Drugs 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 229920002271 DEAE-Sepharose Polymers 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000013028 medium composition Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000005185 salting out Methods 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- 241000588624 Acinetobacter calcoaceticus Species 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- -1 D-mannite Chemical compound 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 206010018265 Gigantism Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 108010079870 Sarcosine Dehydrogenase Proteins 0.000 description 1
- 108010060059 Sarcosine Oxidase Proteins 0.000 description 1
- 102000013000 Sarcosine dehydrogenase Human genes 0.000 description 1
- 102000008118 Sarcosine oxidase Human genes 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229960000510 ammonia Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229940044197 ammonium sulfate Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 108010029444 creatinine deiminase Proteins 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000028564 filamentous growth Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- AJDUTMFFZHIJEM-UHFFFAOYSA-N n-(9,10-dioxoanthracen-1-yl)-4-[4-[[4-[4-[(9,10-dioxoanthracen-1-yl)carbamoyl]phenyl]phenyl]diazenyl]phenyl]benzamide Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2NC(=O)C(C=C1)=CC=C1C(C=C1)=CC=C1N=NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)NC1=CC=CC2=C1C(=O)C1=CC=CC=C1C2=O AJDUTMFFZHIJEM-UHFFFAOYSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000001043 yellow dye Substances 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Description
産業上の利用分野
本発明はクレアチンアミジノハイドロラーゼの
製造方法、特に本発明はアシネトバクター
(Acinetobacter)属に属し、クレアチンアミジ
ノハイドロラーゼ生産能を有する菌株によりクレ
アチンアミジノハイドロラーゼを製造する方法に
関する。
従来技術とその問題点
クレアチンおよびクレアチニンは人間の血液ま
たは尿中に見出され、その量を迅速かつ正確に検
出測定することは人間の病気、例えば尿毒症、慢
性腎炎、急性腎炎、巨人症、強直性筋異栄養症等
を診断するのに非常に重要である。
クレアチンおよびクレアチニンの定量法として
は(1)ピクリン酸を用いるヤツフエ反応に基づく化
学的定量法および(2)クレアチニンデイミナーゼを
用いる酵素的定量方法が知られている。この中上
記(1)の方法は煮沸操作を必要とすること、および
クレアチンおよびクレアチニンに対する特異性が
低い等の欠点を有している。また上記(2)の方法は
内因性アンモニアの作用を受けるので正確性に欠
ける等の問題点があり、迅速かつ正確な方法とは
言えない。
上記(1)および(2)に代わる方法としてクレアチニ
ンアミドハイドロラーゼおよびクレアチンアミジ
ノハイドロラーゼを用いる酵素的定量方法があ
る。これらの中クレアチンアミジノハイドロラー
ゼはクレアチンを加水分解してサルコシンと尿素
を生成させる酵素である。従つて生成するサルコ
シンをサルコシンデヒドロゲナーゼまたはサルコ
シンオキシダーゼを用いる方法により測定すれ
ば、人間の血液中または尿中のクレアチンの量を
知ることができ、上述した各種の病気の診断に利
用することができる。
クレアチンアミジノハイドロラーゼは微生物界
に広く見出されており、既に工業的にも製造さ
れ、臨床検査試薬として使用されている。
クレアチンアミジノハイドロラーゼを生産する
菌株としては今までに次の如き菌株が知られてい
る。
シユードモナス・アエルギノーサ
(Pseudomonas aeruginosa)、(Kopper,P.H.;
Robin,L.;Arch.Biochem.第26巻、第458頁、
1950年)。
シユードモナス・オバリス(Pseudomonas
ovalis)、(Appleyard,G.;Wood,D.D.;J.
Gen.Microbiol.第14巻、第351頁、1956年)。
シユードモナス・プチダ(Pseudomonas
putida)、(Yoshimoto,T.;Oka,I.;Tsuru,
D.;Arch.Biochem.Biophys.第177巻、第508頁、
1976年)。
アースロバクター・ウレアフアシエンス
(Arthrobacter ureaqaciens)、(Kaplan,A.;
Naugler,D.;Mol.Cell Biochem.第3巻、第9
頁、1974年)。
フラボバクテリウム(Flavobacterium)属、
コリネバクテリウム(Corynebacterium)属、マ
イクロコツカス(Micrococcus)属(特開昭51−
118884号)。
アルカリゲネス(Alcaligenes)属、ペニシリ
ウム(Penicillium)属(特開昭47−43281号)。
しかしながら上述した公知の各種菌株から製造
されたクレアチンアミジノハイドロラーゼは至適
PH範囲が7.5〜8.5と非常に狭く、熱安定性が40℃
以下であつて熱に対して不安定であり、Km値が例
えば2.9×10-2Mと大きく、PH安定性も4.5〜8.5で
狭いという欠点を有していた。このため至適PH範
囲が広く、熱安定性が優れ、しかもKm値の小さい
クレアチンアミジノハイドロラーゼが求められて
いる。
発明の目的
本発明は従つて至適PH範囲が広く、熱安定性に
優れ、Km値の小さいクレアチンアミジノハイドロ
ラーゼを得ることにある。
発明の構成
本発明はアシネトバクター(Acinetobacter)
属に属し、クレアチンアミジノハイドロラーゼ生
産能を有する菌株を栄養培地に培養し、培養物中
にクレアチンアミジノハイドロラーゼを生成蓄積
せしめ、これを採取することからなるクレアチン
アミジノハイドロラーゼの製造方法にある。
本発明で使用する菌株はアシネトバクター
(Acinetobacter)属に属する菌株であるならば
何れでも良いが、特に本発明者等福井県敦賀市内
の土譲より採取したアシネトバクター
(Acinetobacter)属に属するアシネトバクター
(Acinetobacter)CRH−1040株が好ましい。
上記アシネトバクター(Acinetobacter)CRH
−1040株の菌学的性質を以下に示す。
(a) 形態
肉汁寒天培地に30℃で20時間培養して大きさ
(1.0〜1.5μ)×(1.5〜2.0μ)の桿菌であり、グラム
染色は陰性であり、運動性はない。
(b) 各培地における生育状態
(1) 肉汁寒天平板培養
30℃,48時間で直径3〜5mmの円形のコロ
ニーを形成する。表面は平滑で光択があり、
隆起は凸円状、コロニーは均質不透明で淡い
クリーム色で、可溶性色素は形成しない。
(2) 肉汁寒天斜面培養
30℃,20時間で糸状良好な生育を示す。コ
ロニーは淡いクリーム色である。
(3) 肉汁液体培養
30℃,16時間振盪培養にて生育し、濁化す
る。
(4) 肉汁ゼラチン穿刺培養
30℃,16時間培養にて生育し、ゼラチン液
化能はない。
(5) リトマスミルク
変化なし。
(c) 生理学的性質
(1) 硝酸塩の還元;陰性
(2) 脱室反応;陰性
(3) MRテスト;陰性
(4) VPテスト;陽性
(5) インドールの生成;陰性
(6) 硫化水素の生成;陰性
(7) デンプンの加水分解;陰性
(8) クエン酸の利用;陰性
(9) 無機窒素源の利用;陰性
(10) 色素の生成;なし
(11) ウレアーゼ;陽性
(12) オキシダーゼ;陰性
(13) カタラーゼ;陽性
(14) 生育の範囲;生育温度15〜30℃、至適温
度20〜25℃、生育PH5.0〜8.0、至適PH6.0〜
7.5
(15) 酵素に対する態度;好気性
(16) O−Fテスト;酸化
(17) 糖からの酸の生成;D−フラクトース、
D−ガラクトース、麦芽糖、乳糖、D−ソル
ビツト、D−マンニツト、イノシツト等から
酸を生成する。
(18) その他
アルギニンの分解;陰性。リジンの脱炭酸反
応;陽性。オルニチンの脱炭酸反応;陰性。
上記菌学的性質の同定のための実験法は主とし
て長谷川武治編著、「微生物の分類と同定」学会
出版センター(1975年)によつて行なつた。また
分類同定の基準としてバージス・マニユアル・オ
ブ・デターミネイテイブ・バクテリオロジー第8
版(1974年)を参考にした。
上記文献および上記菌学的性質からCRH−
1040株はアシネトバクター(Acinetobacter)属
に属するとみなされる。しかしながら上記文献に
は上記菌種の菌学的性質は多くは記載されていな
い。アシネトバクター・カルコアセチカス
(Acinetobacter calcoaceticus)とよく一致する
が、リジン脱炭酸反応の点において相異が認めら
れる。従つて本菌株はアシネトバクター
(Acinetobacter)属CRH−1040株と命名した。
本菌は工業技術院微生物工業研究所に微生物受託
番号微工研菌寄第7718号として寄託されている。
本発明方法を実施するに当つては、通常の栄養
培地を使用できるが、好ましくはクレアチン、ク
レアチニンまたはそれらの誘導体を用いて培養す
るのが好ましい。培地の炭素源としてはクレアチ
ニン、クレアチン、グルコース、シユクロース、
フラクトース、澱粉、廃糖蜜、アルコール類、有
機酸類が利用でき、天然栄養源としてはペプト
ン、肉エキス、酵母エキス、コーンステイープリ
カー等が利用でき、窒素源としてはクレアチニ
ン、クレアチン、アンモニア、硫安、硝安、塩
安、尿素等が利用でき、無機塩類としてはリン酸
カリウム、塩化カリウム、塩化ナトリウム、硫酸
マグネシウム等が利用できる。これらの営養源は
それぞれ単独で用いることもできまた組合せて用
いることもできる。
菌株を培養するに当つては、通常振盪培養また
は通気撹拌培養で行なうことができる。一般に培
養温度は25〜35℃、培地PHは6.5〜7.5であるのが
好ましく、通常1〜2日間培養を行なうと、菌体
中にクレアチンアミジノハイドロラーゼが生成蓄
積する。培養条件は使用する菌株、培地組成等に
応じ、クレアチンアミジノハイドロラーゼの生産
量が最大になるように設定することは当然であ
る。
本発明の方法によつて生成蓄積されたクレアチ
ンアミジノハイドロラーゼを採取するに当つて
は、培養液から遠心分離、過等の操作により菌
体を集め、集めた菌体をビーズ破砕もしくは超音
波破砕等の操作をして菌体中からクレアチンアミ
ジノハイドロラーゼを取り出す。かくして得られ
た粗酵素液からクレアチンアミジノハイドロラー
ゼを単離するに当つては、通常の酵素精製に用い
られる方法を使用できる。例えば塩析、有機溶媒
沈澱、透析、等電点沈澱、イオン交換法、ゲル
過等の方法を組合せて使用できる。例えば粗酵素
液を遠心分離し、上清を得る。さらにその上清の
硫安塩析画分(0.35〜0.55飽和)を得る。一夜透
析後DEAE−セフアロースCL4Bイオン交換体に
吸着、溶出させる。活性画分を濃縮後セフアアク
リルS200のゲル過を行なうことにより高度に
精製されたクレアチンアミジノハイドロラーゼを
単離することができる。
本発明方法により得られるクレアチンアミジノ
ハイドロラーゼの酵素化学的および理化学的性質
は次のとおりである。
(1) 作用:
本発明の酵素は1モルのクレアチンを加水分
解して、1モルのサルコシンと1モルの尿素を
生成する。
(2) 基質特異性:
クレアチンに特異的に作用する。
(3) 至適PH:
本発明の酵素の至適PHは第1図の曲線で表わ
される如くPH7.0〜9.0に高い活性を有してい
る。
(4) 至適温度:
本発明の酵素の至適温度は第2図の曲線で表
わされる如く35℃〜45℃にある。
(5) PH安定性:
本発明の酵素を25℃でそれぞれのPHで17時間
処理したときのPH安定性を第3図に示す。第3
図より明らかな如く、本発明の酵素はPH4.5〜
8.5の間で安定である。
(6) 熱安定性:
本発明の酵素をPH7.5でそれぞれの温度で30
分間処理したときの熱安定性を第4図に示す。
第4図から明らかな如く、本発明の酵素は50℃
まで安定である。
(7) 阻害剤:
下表1に示す如く、硝酸銀、塩化水銀、硫酸
銅で阻害された。
INDUSTRIAL APPLICATION FIELD The present invention relates to a method for producing creatine amidinohydrolase, and more particularly, the present invention relates to a method for producing creatine amidinohydrolase using a strain belonging to the genus Acinetobacter and having the ability to produce creatine amidinohydrolase. PRIOR ART AND ITS PROBLEMS Creatine and creatinine are found in human blood or urine, and rapid and accurate detection and measurement of their amounts is essential for human diseases such as uremia, chronic nephritis, acute nephritis, gigantism, It is very important for diagnosing tonic myodystrophy. Known methods for quantifying creatine and creatinine include (1) a chemical assay based on the Jacques reaction using picric acid, and (2) an enzymatic assay using creatinine deiminase. Among these, method (1) above has drawbacks such as requiring a boiling operation and low specificity for creatine and creatinine. In addition, method (2) above has problems such as lack of accuracy because it is affected by endogenous ammonia, and cannot be said to be a quick and accurate method. As an alternative to (1) and (2) above, there is an enzymatic quantitative method using creatinine amide hydrolase and creatine amidino hydrolase. Among these, creatine amidinohydrolase is an enzyme that hydrolyzes creatine to produce sarcosine and urea. Therefore, by measuring the produced sarcosine by a method using sarcosine dehydrogenase or sarcosine oxidase, the amount of creatine in human blood or urine can be determined, and this can be used to diagnose the various diseases mentioned above. Creatine amidinohydrolase is widely found in the microbial world, and has already been produced industrially and used as a clinical test reagent. The following strains are known to date as strains that produce creatine amidinohydrolase. Pseudomonas aeruginosa, (Kopper, PH;
Robin, L.; Arch.Biochem. vol. 26, p. 458,
1950). Pseudomonas obalis
ovalis), (Appleyard, G.; Wood, DD; J.
Gen. Microbiol. vol. 14, p. 351, 1956). Pseudomonas putida
(Yoshimoto, T.; Oka, I.; Tsuru,
D.; Arch.Biochem.Biophys. Volume 177, Page 508,
(1976). Arthrobacter ureaqaciens, (Kaplan, A.;
Naugler, D.; Mol. Cell Biochem. Volume 3, No. 9
Page, 1974). Genus Flavobacterium,
Corynebacterium genus, Micrococcus genus (Japanese Patent Application Laid-open No. 1973-
No. 118884). Genus Alcaligenes, Genus Penicillium (Japanese Patent Application Laid-Open No. 47-43281). However, creatine amidinohydrolase produced from the various known strains mentioned above is optimal.
Very narrow PH range of 7.5 to 8.5 and thermal stability of 40℃
It has the drawbacks that it is unstable to heat, has a large Km value of, for example, 2.9×10 −2 M, and has a narrow PH stability of 4.5 to 8.5. Therefore, there is a need for a creatine amidinohydrolase that has a wide optimum pH range, excellent thermostability, and a low Km value. OBJECTS OF THE INVENTION The object of the present invention is therefore to obtain a creatine amidinohydrolase that has a wide optimum pH range, excellent thermostability, and a small Km value. Structure of the Invention The present invention relates to Acinetobacter.
The present invention provides a method for producing creatine amidinohydrolase, which comprises culturing a strain belonging to the genus genus creatine amidinohydrolase and having the ability to produce creatine amidinohydrolase in a nutrient medium, producing and accumulating creatine amidinohydrolase in the culture, and collecting the same. The strain used in the present invention may be any strain as long as it belongs to the genus Acinetobacter, but in particular the strain of Acinetobacter belonging to the genus Acinetobacter collected by the present inventors from a soil concession in Tsuruga City, Fukui Prefecture. ) CRH-1040 strain is preferred. Acinetobacter CRH mentioned above
The mycological properties of strain -1040 are shown below. (a) Morphology When cultured on broth agar medium at 30°C for 20 hours, it is a bacillus with a size of (1.0-1.5μ) x (1.5-2.0μ), Gram staining is negative, and it is not motile. (b) Growth status in each medium (1) Broth agar plate culture Form circular colonies with a diameter of 3 to 5 mm at 30°C for 48 hours. The surface is smooth and has light selection.
The ridges are convex and circular, and the colonies are homogeneous, opaque, pale cream in color, and do not form soluble pigments. (2) Meat juice agar slant culture shows good filamentous growth at 30°C for 20 hours. Colonies are pale cream in color. (3) Meat juice liquid culture Grow in shaking culture at 30℃ for 16 hours and become cloudy. (4) Meat juice gelatin puncture culture Grows in culture at 30℃ for 16 hours and has no ability to liquefy gelatin. (5) Litmus milk No change. (c) Physiological properties (1) Reduction of nitrate; negative (2) Breaking room reaction; negative (3) MR test; negative (4) VP test; positive (5) Formation of indole; negative (6) Hydrogen sulfide Formation; negative (7) Hydrolysis of starch; negative (8) Use of citric acid; negative (9) Use of inorganic nitrogen source; negative (10) Formation of pigment; none (11) Urease; positive (12) Oxidase; Negative (13) Catalase; Positive (14) Growth range; Growth temperature 15-30℃, optimum temperature 20-25℃, growth PH5.0-8.0, optimum PH6.0-
7.5 (15) Attitude towards enzymes; aerobic (16) O-F test; oxidation (17) Production of acids from sugars; D-fructose,
Acid is produced from D-galactose, maltose, lactose, D-sorbitol, D-mannite, inositol, etc. (18) Others Degradation of arginine; negative. Lysine decarboxylation reaction; positive. Ornithine decarboxylation reaction; negative. The experimental methods for identifying the above-mentioned mycological properties were mainly carried out in "Classification and Identification of Microorganisms" edited by Takeji Hasegawa, Society Publishing Center (1975). In addition, Burgess Manual of Determinative Bacteriology No. 8 is used as a standard for taxonomic identification.
(1974) as reference. From the above literature and the above mycological properties, CRH-
Strain 1040 is considered to belong to the genus Acinetobacter. However, the above-mentioned literature does not describe much of the mycological properties of the above-mentioned bacterial species. It closely matches Acinetobacter calcoaceticus, but there are differences in the lysine decarboxylation reaction. Therefore, this bacterial strain was named Acinetobacter genus CRH-1040 strain.
This bacterium has been deposited with the Institute of Microbiology, Agency of Industrial Science and Technology under microbial accession number 7718. In carrying out the method of the present invention, a conventional nutrient medium can be used, but it is preferable to culture using creatine, creatinine, or a derivative thereof. Carbon sources for the medium include creatinine, creatine, glucose, sucrose,
Fructose, starch, molasses, alcohols, and organic acids can be used; peptone, meat extract, yeast extract, cornstarch liquor, etc. can be used as natural nutritional sources; creatinine, creatine, ammonia, ammonium sulfate, etc. can be used as nitrogen sources. Ammonium nitrate, ammonium chloride, urea, etc. can be used, and as inorganic salts, potassium phosphate, potassium chloride, sodium chloride, magnesium sulfate, etc. can be used. Each of these nutritional sources can be used alone or in combination. When culturing the bacterial strain, it can usually be carried out by shaking culture or aerated agitation culture. Generally, the culture temperature is preferably 25 to 35°C and the medium pH is 6.5 to 7.5. Creatine amidinohydrolase is produced and accumulated in the bacterial cells when the culture is generally carried out for 1 to 2 days. It goes without saying that the culture conditions should be set so as to maximize the production of creatine amidinohydrolase depending on the bacterial strain used, medium composition, etc. In collecting the creatine amidinohydrolase produced and accumulated by the method of the present invention, the bacterial cells are collected from the culture solution by centrifugation, sieving, etc., and the collected bacterial cells are crushed with beads or ultrasonic. Creatine amidinohydrolase is extracted from the bacterial cells by the following operations. In isolating creatine amidinohydrolase from the crude enzyme solution thus obtained, a method commonly used for enzyme purification can be used. For example, salting out, organic solvent precipitation, dialysis, isoelectric precipitation, ion exchange, gel filtration, and other methods can be used in combination. For example, a crude enzyme solution is centrifuged to obtain a supernatant. Furthermore, an ammonium sulfate salting out fraction (0.35 to 0.55 saturation) of the supernatant is obtained. After overnight dialysis, it was adsorbed and eluted onto DEAE-Sepharose CL4B ion exchanger. After concentrating the active fraction, highly purified creatine amidinohydrolase can be isolated by gel filtration using Sephaacrylic S200. The enzymatic and physicochemical properties of creatine amidinohydrolase obtained by the method of the present invention are as follows. (1) Action: The enzyme of the present invention hydrolyzes 1 mol of creatine to produce 1 mol of sarcosine and 1 mol of urea. (2) Substrate specificity: Acts specifically on creatine. (3) Optimal PH: The enzyme of the present invention has high activity at a pH of 7.0 to 9.0, as shown by the curve in FIG. (4) Optimal temperature: The optimal temperature for the enzyme of the present invention is between 35°C and 45°C, as shown by the curve in FIG. (5) PH stability: Figure 3 shows the PH stability when the enzyme of the present invention was treated at 25°C for 17 hours at each PH. Third
As is clear from the figure, the enzyme of the present invention has a pH of 4.5 to
It is stable between 8.5 and 8.5. (6) Thermostability: The enzyme of the present invention was incubated at pH 7.5 for 30 min at each temperature.
The thermal stability when treated for minutes is shown in FIG.
As is clear from FIG. 4, the enzyme of the present invention is heated at 50°C.
It is stable until (7) Inhibitors: As shown in Table 1 below, it was inhibited by silver nitrate, mercury chloride, and copper sulfate.
【表】
(8) Km値:
本発明の酵素のKm値は約2.4×10-2Mである。
(9) 分子量:
本発明の酵素は、セフアアクリルS−200を
用いたゲル過法で約100000である。
(10) 酵素活性測定法:
本発明の酵素活性の測定は下記条件で1分間
に1マイクロモルの黄色色素を生成する酵素活
性を1単位とする。
試薬:
(A) 0.1Mクレアチン溶液(1.49gのクレアチ
ンを50mMリン酸緩衝液PH7.5に溶解し、100
mlとする)。
(B) DAB溶液(2.0gのp−ジメチルアミノベ
ンズアルデヒドを100mlのジメチルスルホキ
シドに溶解させた後、濃塩酸15mlを加える)。
(C) 酵素溶液(酵素標品を予め氷冷した50mM
リン酸緩衝液PH7.5で1.0〜4.0U/mlに稀釈す
る。
手順:
1 試験管に上記基質溶液(A)0.9mlを入れ、37
℃で約5分間予備加熱する。
2 上記酵素溶液(C)0.1mlを加え反応を開始す
る。
3 37℃で正確に10分間反応させた後、上記
DAB溶液(B)2.0mlを加えて反応を停止させ
る。
4 25℃で20分間放置後、435nmにおける吸光
度を測定する(ODtest)。
5 盲検は上記基質溶液(A)0.9mlを37℃で10分
間放置後、上記DAB溶液(B)2.0mlを加えて混
和し、次いで酵素溶液(C)0.1mlを加えて調製
する。以下同様に25℃で20分間放置後435nm
における吸光度を測定する(ODblaok)。
計算式:
U/ml=ΔOD(ODtest−ODblaok)×3.0(ml)×稀釈
倍数/0.321×1.0×10(分)×0.1(ml)=ΔOD×9.35
×稀釈倍数
0.321=黄色色素のミリモル分子吸光係数
(cm2/μM)
1.0=光路長(cm)
実施例の説明
以下に本発明によるクレアチンアミジノハイド
ロラーゼの製造法を実施例を挙げて説明する。%
は他の特記せぬ限り(w/v)%である。
実施例 1
培地組成
0.2%クレアチン、0.5%ポリペプトン、0.5%
酵母エキス、1.4%K2HPO4,0.3%KH2PO4,
0.01%MgSO4・7H2O,PH7.0
上記の培地50mlを500mlの坂ロフラスコに入れ、
121℃で10分間オートクレーブ殺菌する。アシネ
トバクター(Acinetobacter)CRH−1040(微工
研菌寄第7718号)の1白金耳を上記培地に接種し
30℃,20時間振盪培養し、種培養液とする。別に
同条件にて殺菌した培地6を含む10容ジヤー
フアメンターへ上記種培養液50mlを接種する。
300rpm、通気量3/min、30℃で16時間培養
する。得られた培養液のクレアチンアミジノハイ
ドロラーゼ活性は0.5U/mlであつた。培養液6
を遠心分離し、菌体を集め50mMリン酸緩衝液
に懸濁し、1としてビーズ破砕機(ダイノミル
KDL)により破砕する。菌体破砕液を遠心分離
し、上清を得る。上清液に0.35飽和になるよう硫
安を加え遠心分離し、上清を得る。その上清液に
さらに0.55飽和になるよう硫安を加え遠心分離
し、沈澱物を得る。50mMリン酸緩衝液PH7.5,
250mlに再溶解する。再溶解液を50mMリン酸緩
衝液PH7.5で平衡化したセフアデツクスG−25カ
ラム(2)で脱塩する。脱塩液をDEAE−セフ
アロースCL−4Bカラム50mlに吸着させ、0.4M
NaClにて溶出する。溶出液を限外過にて濃縮
し、セフアアクリルS−200カラムにて分子篩を
行なう。活性画分の比活性は15.3U/mg蛋白であ
つた。
発明の効果
本発明方法により得られるクレアチンアミジノ
ハイドロラーゼは熱安定性が50℃まで安定であ
り、至適PHが7.0〜9.0と広く、Km値も2.4×10-2M
と小さくすぐれており、かつPH安定性も4.5〜8.5
で従来のものより広い。[Table] (8) Km value: The Km value of the enzyme of the present invention is approximately 2.4×10 -2 M. (9) Molecular weight: The enzyme of the present invention has a molecular weight of about 100,000 as determined by gel filtration using Sephaacryl S-200. (10) Enzyme activity measurement method: In the measurement of the enzyme activity of the present invention, one unit is the enzyme activity that produces 1 micromole of yellow pigment per minute under the following conditions. Reagents: (A) 0.1M creatine solution (dissolve 1.49g creatine in 50mM phosphate buffer PH7.5,
ml). (B) DAB solution (dissolve 2.0 g of p-dimethylaminobenzaldehyde in 100 ml of dimethyl sulfoxide, then add 15 ml of concentrated hydrochloric acid). (C) Enzyme solution (50mM enzyme preparation pre-cooled on ice)
Dilute to 1.0-4.0 U/ml with phosphate buffer PH7.5. Procedure: 1 Put 0.9 ml of the above substrate solution (A) into a test tube and add 37
Preheat at ℃ for about 5 minutes. 2 Add 0.1 ml of the above enzyme solution (C) to start the reaction. 3 After reacting at 37℃ for exactly 10 minutes,
Add 2.0 ml of DAB solution (B) to stop the reaction. 4 After standing at 25°C for 20 minutes, measure the absorbance at 435 nm (OD test ). 5. A blind test is prepared by leaving 0.9 ml of the above substrate solution (A) at 37°C for 10 minutes, then adding and mixing 2.0 ml of the above DAB solution (B), and then adding 0.1 ml of the enzyme solution (C). Similarly, after leaving at 25℃ for 20 minutes, 435nm
Measure the absorbance at (OD blaok ). Calculation formula: U/ml = ΔOD (OD test − OD blaok ) × 3.0 (ml) × dilution factor / 0.321 × 1.0 × 10 (min) × 0.1 (ml) = ΔOD × 9.35
x dilution factor 0.321 = millimolar molecular extinction coefficient of yellow dye (cm 2 /μM) 1.0 = optical path length (cm) Description of Examples The method for producing creatine amidinohydrolase according to the present invention will be described below with reference to Examples. %
is (w/v)% unless otherwise specified. Example 1 Medium composition 0.2% creatine, 0.5% polypeptone, 0.5%
Yeast extract, 1.4% K2HPO4 , 0.3 % KH2PO4 ,
0.01% MgSO4・7H2O , PH7.0 Put 50ml of the above medium into a 500ml Sakaro flask.
Autoclave for 10 minutes at 121 °C. One platinum loop of Acinetobacter CRH-1040 (Feikoken Bacteria No. 7718) was inoculated into the above medium.
Culture with shaking at 30°C for 20 hours and use as a seed culture. Separately, 50 ml of the above seed culture solution is inoculated into a 10-volume jar fermentor containing medium 6 sterilized under the same conditions.
Culture at 300 rpm, aeration rate 3/min, and 30°C for 16 hours. The creatine amidinohydrolase activity of the obtained culture solution was 0.5 U/ml. Culture solution 6
Centrifuge the cells, collect the cells, suspend them in 50mM phosphate buffer, and use a bead crusher (Dynomil) as step 1.
Crush with KDL). Centrifuge the cell suspension to obtain a supernatant. Add ammonium sulfate to the supernatant to a saturation of 0.35 and centrifuge to obtain a supernatant. Add ammonium sulfate to the supernatant to a saturation of 0.55 and centrifuge to obtain a precipitate. 50mM phosphate buffer PH7.5,
Re-dissolve in 250ml. Desalt the redissolved solution using a Sephadex G-25 column (2) equilibrated with 50 mM phosphate buffer PH7.5. Adsorb the desalted solution onto a 50ml DEAE-Sepharose CL-4B column, and add 0.4M
Elute with NaCl. The eluate was concentrated by ultrafiltration and subjected to molecular sieving using a Sephaacrylic S-200 column. The specific activity of the active fraction was 15.3 U/mg protein. Effects of the Invention The creatine amidinohydrolase obtained by the method of the present invention is thermostable up to 50°C, has a wide optimum pH range of 7.0 to 9.0, and has a Km value of 2.4×10 -2 M.
It is small and excellent, and the PH stability is also 4.5 to 8.5.
It is wider than the conventional one.
第1図は本発明により得られたクレアチンアミ
ジノハイドロラーゼのPHと活性の関係を表わし、
第2図は温度と活性の関係を表わし、第3図は25
℃でそれぞれのPHで17時間処理したときのPHと活
性の関係を表わし、第4図はPH7.5でそれぞれの
温度で30分処理したときの温度と活性の関係を表
わす。
FIG. 1 shows the relationship between PH and activity of creatine amidinohydrolase obtained by the present invention,
Figure 2 shows the relationship between temperature and activity, and Figure 3 shows the relationship between temperature and activity.
Figure 4 shows the relationship between PH and activity when treated at PH7.5 for 17 hours at each temperature, and Figure 4 shows the relationship between temperature and activity when treated at PH7.5 and each temperature for 30 minutes.
Claims (1)
し、クレアチンアミジノハイドロラーゼ生産能を
有する菌株を栄養培地に培養し、培養物中にクレ
アチンアミジノハイドロラーゼを生成蓄積せし
め、これを採取することを特徴とするクレアチン
アミジノハイドロラーゼの製造方法。 2 菌株がアシネトバクター(Acinetobacter)
CRH−1040である特許請求の範囲第1項記載の
製造方法。[Claims] 1. A method of culturing a strain belonging to the genus Acinetobacter and having the ability to produce creatine amidinohydrolase in a nutrient medium, producing and accumulating creatine amidinohydrolase in the culture, and collecting the same. Characteristic method for producing creatine amidinohydrolase. 2 The strain is Acinetobacter
The manufacturing method according to claim 1, which is CRH-1040.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19013584A JPS6167485A (en) | 1984-09-11 | 1984-09-11 | Preparation of creatine amidinohydrolase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19013584A JPS6167485A (en) | 1984-09-11 | 1984-09-11 | Preparation of creatine amidinohydrolase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6167485A JPS6167485A (en) | 1986-04-07 |
| JPH0218068B2 true JPH0218068B2 (en) | 1990-04-24 |
Family
ID=16252974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP19013584A Granted JPS6167485A (en) | 1984-09-11 | 1984-09-11 | Preparation of creatine amidinohydrolase |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6167485A (en) |
-
1984
- 1984-09-11 JP JP19013584A patent/JPS6167485A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6167485A (en) | 1986-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4882280A (en) | Uricase and a method for the preparation thereof | |
| JP2850515B2 (en) | Glucose dehydrogenase and method for producing the same | |
| US4740465A (en) | Heat-resistant sarcosine oxidase N and process for producing the same | |
| JP2788174B2 (en) | Novel creatine amidinohydrolase and method for producing the same | |
| JPH0284178A (en) | N-acetyl hexosamine dehydrogenase, its production and quantification of n-acethyl glucosamine or n-acethyl galactosamine using same and kit therefor | |
| JP3216739B2 (en) | Sorbitol oxidase, its production method and its use | |
| JP2672845B2 (en) | Method for producing L-alanine dehydrogenase | |
| US4276377A (en) | Creatinine iminohydrolase free from urease activity | |
| JPH03127985A (en) | L-carnitine dehydrogenase and production thereof | |
| JPH0218067B2 (en) | ||
| JP2684238B2 (en) | Acylcarnitine esterase and method for producing the same | |
| JPH0284177A (en) | L-fucose dehydrogenase, production thereof, method for determining l-fucose therewith and determination kit therefor | |
| JP3114838B2 (en) | Novel creatine amidinohydrolase and its use | |
| JPH0376915B2 (en) | ||
| JP3642344B2 (en) | Method for producing creatine amidinohydrolase | |
| JPH0787780B2 (en) | Novel sarcosine oxidase and its production method | |
| JPH0224517B2 (en) | ||
| JPS6050437B2 (en) | Method for producing creatinine amidohydrolase and/or creatine amidinohydrolase | |
| JPH0638756B2 (en) | Pyruvate assay using pyruvate oxidase and its reagent | |
| WO1994001539A1 (en) | A highly specific sarcosine oxidase | |
| JPH0134036B2 (en) | ||
| JPS6167485A (en) | Preparation of creatine amidinohydrolase | |
| JPS584551B2 (en) | Method for producing choline oxidase | |
| JPH1156355A (en) | Method for producing cholesterol esterase | |
| JPH0337B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |